Bionovate Technologies Corp
BIIO
Get informed when a big investor buys or sells
+ FollowMarket Cap$775
Close$
Share Statistics
| Market cap | $775.00 |
|---|---|
| Enterprise Value | $238,303.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $0 |
| Beta | -2.51 |
| Outstanding Shares | 7,753,598 |
Return
| Return on Equity | 20.06% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | 9.20% |
Valuation & Multiples
| P/E Ratio | -0.04 |
|---|---|
| PEG | 0.77 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -4.94 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 1 |
| Debt to Equity | -0.45 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Bionovate Technologies Corp
0
CEO: Timothy Jones Bionovate Technologies Corp. is a medical device enterprise dedicated to pioneering automated solutions for the treatment of age spots. Its core objective is to engineer a sophisticated, computer-driven system designed to precisely targe...